Indonesia Herbal Remedies Firm Owners Weighing $500 Million Sale

  • Deltomed is backed by Saratoga Investama, Rahardjo family
  • Herbal product maker could be valued at $500 million in deal

Antangin

Source: Deltomed
Lock
This article is for subscribers only.

The owners of PT Deltomed Laboratories are exploring a sale of the Indonesian herbal remedies manufacturer and distributor in a deal that could value the company at about $500 million, according to people with knowledge of the matter.

Indonesian buyout firm PT Saratoga Investama Sedaya and the Rahardjo family are working with an adviser on the potential divestment, said the people, who asked not to be identified as the process is private. The sellers began sounding out potential buyers last week, said the people.